Somaxon Pharmaceuticals' P2P Acquisition

Somaxon Pharmaceuticals raised a round of funding on December 11, 2012. Investors include Pernix Therapeutics Holdings.

Somaxon Pharmaceuticals is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary products and late-stage product candidates for the treatment…

Articles about Somaxon Pharmaceuticals' P2P Acquisition: